Preliminary safety and efficacy data on two patients with relapsed/refractory CNS lymphoma treated with emavusertib (CA-4948) and ibrutinib combination: A subset analysis of TakeAim Lymphoma trial Meeting Abstract
| Authors: | Iqbal, M.; Tun, H.; Joffe, E.; Grommes, C.; Nowakowski, G.; Lunning, M.; Ramchandren, R.; Li, C. C.; Zhao, W.; Martinez, E.; von Roemeling, R.; Earhart, R.; McMahon, M.; Isufi, I.; Leslie, L.; Rosenthal, A. |
| Abstract Title: | Preliminary safety and efficacy data on two patients with relapsed/refractory CNS lymphoma treated with emavusertib (CA-4948) and ibrutinib combination: A subset analysis of TakeAim Lymphoma trial |
| Meeting Title: | 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 24 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Nov 16-20 |
| Meeting Location: | Tampa Bay, FL |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-11-01 |
| Start Page: | vii68 |
| End Page: | vii69 |
| Language: | English |
| ACCESSION: | WOS:000888571000269 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noac209.266 |
| Notes: | Meeting Abstract: CTIM-34 -- Source: Wos |
Altmetric
Citation Impact
Related MSK Work